These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

753 related items for PubMed ID: 11383871

  • 1. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
    Min JJ, Chung JK, Lee YJ, Jeong JM, Lee DS, Jang JJ, Lee MC, Cho BY.
    Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
    [Abstract] [Full Text] [Related]

  • 2. Relationship between expression of the sodium/iodide symporter and (131)I uptake in recurrent lesions of differentiated thyroid carcinoma.
    Min JJ, Chung JK, Lee Y, Jeong J, Lee D, Jang J, Lee M, Cho B.
    Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 24633540
    [Abstract] [Full Text] [Related]

  • 3. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK, So Y, Lee JS, Choi CW, Lim SM, Lee DS, Hong SW, Youn YK, Lee MC, Cho BY.
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [Abstract] [Full Text] [Related]

  • 4. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
    Shiga T, Tsukamoto E, Nakada K, Morita K, Kato T, Mabuchi M, Yoshinaga K, Katoh C, Kuge Y, Tamaki N.
    J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516
    [Abstract] [Full Text] [Related]

  • 5. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF, Oei HY, Hennemann G, Krenning EP.
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [Abstract] [Full Text] [Related]

  • 6. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
    Feine U, Lietzenmayer R, Hanke JP, Held J, Wöhrle H, Müller-Schauenburg W.
    J Nucl Med; 1996 Sep; 37(9):1468-72. PubMed ID: 8790195
    [Abstract] [Full Text] [Related]

  • 7. Relationship of sodium/iodide symporter expression with I131 whole body scan uptake between primary and metastatic lymph node papillary thyroid carcinomas.
    Lee SJ, Choi KC, Han JP, Park YE, Choi MG.
    J Endocrinol Invest; 2007 Jan; 30(1):28-34. PubMed ID: 17318019
    [Abstract] [Full Text] [Related]

  • 8. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
    Gutiérrez Cardo AL, Rodríguez Rodríguez JR, Borrego Dorado I, Navarro González E, Tirado Hospital JL, Vázquez Albertino R.
    Rev Esp Med Nucl; 2007 Jan; 26(3):138-45. PubMed ID: 17524307
    [Abstract] [Full Text] [Related]

  • 9. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P, Kohlfürst S.
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic Capabilities of MRI Versus 18F FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, 131I-negative Local Recurrent or Metastatic Thyroid Cancer.
    Samanci C, Onal Y, Sager S, Asa S, Ustabasioglu FE, Alis D, Akman C, Sonmezoglu K.
    Curr Med Imaging Rev; 2019 Jul; 15(10):956-964. PubMed ID: 32008523
    [Abstract] [Full Text] [Related]

  • 11. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
    Hilditch TE, Dempsey MF, Bolster AA, McMenemin RM, Reed NS.
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake.
    Castro MR, Bergert ER, Goellner JR, Hay ID, Morris JC.
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5627-32. PubMed ID: 11701745
    [Abstract] [Full Text] [Related]

  • 13. Relationship between serum thyroglobulin and 18FDG-PET/CT in 131I-negative differentiated thyroid carcinomas.
    Giovanella L, Ceriani L, De Palma D, Suriano S, Castellani M, Verburg FA.
    Head Neck; 2012 May; 34(5):626-31. PubMed ID: 21850699
    [Abstract] [Full Text] [Related]

  • 14. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Gomez I, Lind P.
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [Abstract] [Full Text] [Related]

  • 15. [Results of radioiodine therapy in patients with pulmonary metastases of differentiated thyroid cancer].
    Ono Y, Yamamoto Y, Nishiyama Y, Nakano S, Takahashi K, Kawasaki Y, Satoh K, Ohkawa M, Tanabe M.
    Kaku Igaku; 2000 Nov; 37(6):661-70. PubMed ID: 11193452
    [Abstract] [Full Text] [Related]

  • 16. Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels.
    Muros MA, Llamas-Elvira JM, Ramírez-Navarro A, Gómez MJ, Rodríguez-Fernández A, Muros T, López de la Torre M, Becerra A, Carreras JL.
    Am J Surg; 2000 Jun; 179(6):457-61. PubMed ID: 11004330
    [Abstract] [Full Text] [Related]

  • 17. 18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience.
    Bertagna F, Albano D, Bosio G, Piccardo A, Dib B, Giubbini R.
    Curr Radiopharm; 2016 Jun; 9(3):228-234. PubMed ID: 27210819
    [Abstract] [Full Text] [Related]

  • 18. Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
    Weber T, Ohlhauser D, Hillenbrand A, Henne-Bruns D, Reske SN, Luster M.
    Horm Metab Res; 2012 Nov; 44(12):904-8. PubMed ID: 22791600
    [Abstract] [Full Text] [Related]

  • 19. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
    Alam MS, Takeuchi R, Kasagi K, Misaki T, Miyamoto S, Iida Y, Hidaka A, Konishi J.
    Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
    [Abstract] [Full Text] [Related]

  • 20. Comparison of 99Tcm-tetrofosmin with 201Tl and 131I in the detection of differentiated thyroid cancer metastases.
    Nishiyama Y, Yamamoto Y, Ono Y, Takahashi K, Nakano S, Satoh K, Ohkawa M, Tanabe M.
    Nucl Med Commun; 2000 Oct; 21(10):917-23. PubMed ID: 11130332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.